tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RLAY Stock Latest News

Relay Therapeutics price target raised to $22 from $15 at Guggenheim
The FlyRelay Therapeutics price target raised to $22 from $15 at Guggenheim
2h ago
NVS
RLAY
Relay Therapeutics Updates Bylaws on Federal Securities Litigation
PremiumCompany Announcements
Relay Therapeutics Updates Bylaws on Federal Securities Litigation
2d ago
8K
RLAY
Relay Therapeutics reports Q4 EPS (32c), consensus (39c)
PremiumThe Fly
Relay Therapeutics reports Q4 EPS (32c), consensus (39c)
15d ago
RLAY
RLAY Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RLAY Upcoming Earnings Report: What to Expect?
24d ago
RLAY
Relay Therapeutics Wins FDA Breakthrough Therapy Designation
PremiumCompany Announcements
Relay Therapeutics Wins FDA Breakthrough Therapy Designation
1M ago
8K
RLAY
Relay Therapeutics announces U.S. FDA granted BTD to zovegalisib
PremiumThe FlyRelay Therapeutics announces U.S. FDA granted BTD to zovegalisib
1M ago
RLAY
Relay Therapeutics upgraded at Oppenheimer ahead of VIKTORIA-1 readout
Premium
The Fly
Relay Therapeutics upgraded at Oppenheimer ahead of VIKTORIA-1 readout
2M ago
RLAY
Relay Therapeutics upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
Relay Therapeutics upgraded to Outperform from Perform at Oppenheimer
2M ago
RLAY
Private Markets: SpaceX interviews banks to lead IPO, Skild AI raises $1.4B
PremiumThe Fly
Private Markets: SpaceX interviews banks to lead IPO, Skild AI raises $1.4B
2M ago
V
MA
Relay Therapeutics announces analysis of data for zovegalisib
PremiumThe Fly
Relay Therapeutics announces analysis of data for zovegalisib
3M ago
RLAY
Relay Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
Relay Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
3M ago
RLAY
Relay Therapeutics: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
PremiumRatings
Relay Therapeutics: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
4M ago
RLAY
Relay Therapeutics Reports Q3 2025 Financial Progress
PremiumCompany AnnouncementsRelay Therapeutics Reports Q3 2025 Financial Progress
4M ago
RLAY
Relay Therapeutics reports Q3 EPS (43c), consensus (42c)
Premium
The Fly
Relay Therapeutics reports Q3 EPS (43c), consensus (42c)
4M ago
RLAY
Relay Therapeutics Expands Board with New Appointments
Premium
Company Announcements
Relay Therapeutics Expands Board with New Appointments
4M ago
8K
RLAY
Relay Therapeutics’ Promising Phase 2 Study on RLY-2608: A Potential Game-Changer in Targeted Therapy
PremiumCompany Announcements
Relay Therapeutics’ Promising Phase 2 Study on RLY-2608: A Potential Game-Changer in Targeted Therapy
6M ago
RLAY
Guggenheim assumes Relay with Buy, names best idea
PremiumThe Fly
Guggenheim assumes Relay with Buy, names best idea
6M ago
RLAY
Relay Therapeutics assumed with a Buy at Guggenheim
PremiumThe Fly
Relay Therapeutics assumed with a Buy at Guggenheim
6M ago
RLAY
Relay Therapeutics price target lowered to $14 from $16 at H.C. Wainwright
PremiumThe Fly
Relay Therapeutics price target lowered to $14 from $16 at H.C. Wainwright
7M ago
RLAY
Relay Therapeutics price target lowered to $19 from $29 at Raymond James
PremiumThe FlyRelay Therapeutics price target lowered to $19 from $29 at Raymond James
7M ago
RLAY
Relay Therapeutics Reports Q2 2025 Financial Results and Progress
Premium
Company Announcements
Relay Therapeutics Reports Q2 2025 Financial Results and Progress
7M ago
RLAY
Relay Therapeutics reports Q2 EPS (41c), consensus (47c)
Premium
The Fly
Relay Therapeutics reports Q2 EPS (41c), consensus (47c)
7M ago
RLAY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >